150151-14-7 Usage
Description
1-(2-(2-(diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine, also known as FPL 64176, is a homopiperazine class chemical compound characterized by its selective and potent antagonistic activity against the serotonin 5-HT1B and 5-HT1D receptors in the brain. This unique property positions it as a promising candidate for the treatment of various neurological and mental health conditions.
Uses
Used in Neuropharmacology:
1-(2-(2-(diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine is used as a therapeutic agent for treating neurological conditions such as migraines, anxiety, and depression. Its antagonistic activity against serotonin receptors helps alleviate symptoms associated with these conditions by modulating the serotonin levels in the brain.
Used in Mental Health:
In the field of mental health, 1-(2-(2-(diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine is used as a potential treatment for mood disorders and other psychiatric conditions. Its interaction with serotonin receptors may contribute to the regulation of mood and emotional well-being.
Used in Erectile Dysfunction Treatment:
1-(2-(2-(diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine is also being studied for its potential use as a treatment for erectile dysfunction. Its effects on serotonin receptors may help improve blood flow and overall sexual function in men experiencing this condition.
Used in Premature Ejaculation Treatment:
Additionally, 1-(2-(2-(diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine is being investigated for its potential application in treating premature ejaculation. Its antagonistic activity on serotonin receptors may help regulate the refractory period and improve sexual performance in affected individuals.
Further research on 1-(2-(2-(diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine's potential therapeutic applications is ongoing, particularly in the fields of neuropharmacology and mental health, as its unique chemical structure and receptor interactions offer promising avenues for the development of novel treatments for various conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 150151-14-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,1,5 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 150151-14:
(8*1)+(7*5)+(6*0)+(5*1)+(4*5)+(3*1)+(2*1)+(1*4)=77
77 % 10 = 7
So 150151-14-7 is a valid CAS Registry Number.
InChI:InChI=1/C29H36N2O/c1-4-12-26(13-5-1)14-10-19-30-20-11-21-31(23-22-30)24-25-32-29(27-15-6-2-7-16-27)28-17-8-3-9-18-28/h1-9,12-13,15-18,29H,10-11,14,19-25H2
150151-14-7Relevant articles and documents
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)
Matecka, Dorota,Rothman, Richard B.,Radesca, Lilian,De Costa, Brian R.,Dersch, Christina M.,Partilla, John S.,Pert, Agu,Glowa, John R.,Wojnicki, Francis H. E.,Rice, Kenner C.
, p. 4704 - 4716 (2007/10/03)
The design, synthesis, and biological evaluation of compounds related to the dopamine (DA) uptake inhibitors: 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (1) and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (2) (GBR
